Insights

Saliva Advantage Abogen focuses on saliva-based research and diagnostics as an alternative to blood, presenting a potential selling point for labs and clinics seeking less invasive sample collection and improved patient experience.

Vaccine Collaboration Active engagement in mRNA vaccine development and partnerships with CanSino, Walvax, and Abogen for Covid-19, dengue, TB, meningitis, and HPV opportunities; leverage these to offer collaborative R&D and manufacturing support.

Early Stage Scale Small team size (2-10 employees) coupled with rapid funding signals a priority on strategic partnerships and outsourcing rather than in-house capacity; position for advisory, CRO, and contract development opportunities.

Funding Signal Recent Series C financing and a mid-range revenue profile suggest growing credibility; approach investors and portfolio companies with co-development and grant-aligned funding proposals for novel saliva-based assays.

Tech Enablement Cloud and web-based tech stack (AWS, WordPress, Google Workspace, data visualization tools) offers an accessible foundation for digital collaboration, data sharing, and remote clinical study support; propose SaaS integrations and data management solutions tailored to small biotech teams.

Similar companies to Abogen, Inc.

Abogen, Inc. Tech Stack

Abogen, Inc. uses 8 technology products and services including Amazon Web Services, WordPress, Google Workspace, and more. Explore Abogen, Inc.'s tech stack below.

Abogen, Inc.'s Email Address Formats

Abogen, Inc. uses at least 2 email formats:
Abogen, Inc. Email FormatsExamplePercentage
FLast@abogen.comJDoe@abogen.com
89%
F.Last@abogen.comJ.Doe@abogen.com
11%

Frequently Asked Questions

What is Abogen, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Abogen, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Abogen, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Abogen, Inc.'s official website is abogen.com and has social profiles on LinkedIn.

How much revenue does Abogen, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Abogen, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Abogen, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Abogen, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abogen, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Abogen, Inc. has approximately 3 employees across 2 continents, including North America and Asia. Key team members include Chief Innovation Officer: M. J. Explore Abogen, Inc.'s employee directory with LeadIQ.

What industry does Abogen, Inc. belong to?

Minus sign iconPlus sign icon
Abogen, Inc. operates in the Biotechnology Research industry.

What technology does Abogen, Inc. use?

Minus sign iconPlus sign icon
Abogen, Inc.'s tech stack includes Amazon Web Services, WordPress, Google Workspace, Chart.js, jQuery, Trustpilot, Bootstrap and prettyPhoto.

What is Abogen, Inc.'s email format?

Minus sign iconPlus sign icon
Abogen, Inc.'s email format typically follows the pattern of FLast@abogen.com. Find more Abogen, Inc. email formats with LeadIQ.

How much funding has Abogen, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Abogen, Inc. has raised $1.4M in funding. The last funding round occurred on Jul 01, 2016.

When was Abogen, Inc. founded?

Minus sign iconPlus sign icon
Abogen, Inc. was founded in 2012.
Abogen, Inc. logo

Abogen, Inc.

Biotechnology ResearchMaine, United States2-10 Employees

Abogen, Inc. operates in biotechnology research with a focus on reducing the need for invasive blood draws in research and diagnostic workflows. Founded in 2012, the company asserts that saliva can be used for a range of cell-based applications, including serological and genetic analyses, and has demonstrated this with independent validators. It emphasizes elevating saliva as an alternative to blood rather than replacing it entirely, and it is based in Portland, Maine, operating with a small team. 

Positioned within the biotechnology research industry, Abogen aims to supply researchers and diagnostic developers with saliva-based approaches to support cell-based tests and analyses. A 2022 report notes the company’s involvement in developing mRNA-based vaccines for Covid-19 and dengue, along with provisional collaboration discussions with CanSino and Walvax to pursue additional vaccine programs.

Section iconCompany Overview

Phone number
Website
abogen.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
2-10

Section iconFunding & Financials

  • $1.4M

    Abogen, Inc. has raised a total of $1.4M of funding over 12 rounds. Their latest funding round was raised on Jul 01, 2016 as a Seed.

  • $1M - $10M

    Abogen, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.